CASE SOLUTION FOR PHARMACYCLICS: FINANCING RESEARCH & DEVELOPMENT

Dear Students,

Our tutors are available 24/7 to assist in your academic stuff, Our Professional writers are ready to serve you in services you need. We do assist you in solving case for "PHARMACYCLICS: FINANCING RESEARCH & DEVELOPMENT"

Complete Case details are given below :

Case Name :      Pharmacyclics: Financing Research & Development
Authors :           Richard S. Ruback, Malcolm P. Baker, Aldo Sesia
Discipline :        Finance
Case Length :    14 pages
Solution sample availability : YES
Plagiarism : NO (100% Original work)

Description for case is given below :
Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for cancer, arteriosclerosis, and retinal disease, was considering a $60 million private placement in February 2000. The company had more cash than ever before, but projections of R&D and marketing expenses were also unprecedented. PCYC's most promising oncology drug, a radiation enhancer called Xcytrin, was in Phase III clinical trials--the rigorous final phase before FDA approval for commercialization. Analysts gave the drug a slightly better than 50% chance of success. This case focuses on stage financing and a simple decision-tree evaluation. Students have the opportunity to consider the impact of past staged financing decisions on the ownership structure of the firm and to evaluate the current stock market price in light of analyst forecasts of the cash flow and the probability of success for each drug. These two analyses help inform the private placement decision.

Click Here to place your order

OR

Place your order at casestudieshelp (AT)gmail(dot)com if you want to solve above case.

Cordially,

Case Studies Help